← Back to Clinical Trials
Recruiting NCT07428928

NCT07428928 Effects of Play Based Neural Mobilisation Activities on Hand Grip Strength and Dexterity in Cerebral Palsy Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07428928
Status Recruiting
Phase —
Sponsor Riphah International University
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2025-10-29
Primary Completion 2026-02-20

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
neural mobilization which include ulnar, median and radial nerves mobilisation by a play activity called "Simon says" in addition to the routine physical therapy treatment.Regular physical therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 34 participants in total. It began in 2025-10-29 with a primary completion date of 2026-02-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study design will be a Randomized control trial. The data will be collected from Acme Medical complex and Rehab cure clinic. The study will be completed in 10 months after the approval of synopsis. The sampling technique will be non-probability convenient sampling. Sample size is 16 calculated by epitool. Group A will receive Routine Physical therapy with play based neural mobilization activity method and Group B will receive Routine Physical therapy with baseline treatment. Diplegic cerebral palsy girls and boys included with age limit 6-12 years and without history of injury 1 year, Patients who cannot obey commands will be excluded. Hand dynamometer and pegboard test will used as outcome tool. Single blinding will be used. Data Analysis will be done on Statistical Package for the Social Sciences (SPSS) version 23.00.

Eligibility Criteria

Inclusion Criteria: * Inclusion Criteria: * Diplegic cerebral palsy patients * Both Girls and boys included * Age limit 6-12 years * CP child with Gross Motor Function Classification System (GMFCS) level III and IV(20) * CP child at MACS level II and III Exclusion Criteria: * • Patients with history of injury in 1 year. * Patients who cannot obey commands * CP children with associated scoliosis

Contact & Investigator

Central Contact

IMRAN AMJAD, PhD

✉ imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

Uzma Irshad, MS-PT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07428928 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07428928 currently recruiting?

Yes, NCT07428928 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07428928 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07428928 clinical trial?

NCT07428928 is sponsored by Riphah International University. The principal investigator is Uzma Irshad, MS-PT at Riphah International University. The trial plans to enroll 34 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology